They have been given a long leash for a long time for a reason. Cheap outsourcing. Regulations are not keeping pace as the are not effecting domestic markets. In this instance regulations are now being used to apply pressure to outside markets to secure market monopolies in domestic markets. These are full blown patient wars going on, example:
http://www.thepharmaletter.com/file/330 ... spute.htmlDomestic supply is simply collateral damage.
$1:
Meanwhile, Health Canada is encouraging the pharmaceutical industry and professional health-care associations to continue to collaborate to establish a national, one-stop drug shortages monitoring and reporting system.
This is why we need a national drug program.